{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:47:48Z","timestamp":1762145268841,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.dsx.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T02:31:43Z","timestamp":1499481103000},"page":"S833-S839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S2","title":["Evaluation of current trends and recent development in insulin therapy for management of diabetes mellitus"],"prefix":"10.1016","volume":"11","author":[{"given":"Muhammad Sarfraz","family":"Nawaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kifayat Ullah","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahir Mehmood","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haroon Ur","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajid","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Junaid","family":"Farrukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.dsx.2017.07.003_bib0005","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus\u2014present and future perspectives","volume":"8","author":"Chen","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.dsx.2017.07.003_bib0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.2040-1124.2010.00074.x","article-title":"Report of the committee on the classification and diagnostic criteria of diabetes mellitus","volume":"1","author":"Seino","year":"2010","journal-title":"J Diabetes Invest"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.003_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b7 9 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.dsx.2017.07.003_bib0020","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/dc12-1513","article-title":"All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large UK primary care database","volume":"36","author":"Taylor","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.003_bib0025","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.003_bib0030","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/dom.12098","article-title":"The use of insulin analogues in pregnancy Diabetes","volume":"15","author":"Lambert","year":"2013","journal-title":"Obesity Metab"},{"issue":"12","key":"10.1016\/j.dsx.2017.07.003_bib0035","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.2337\/dc12-1956","article-title":"Day and Night Closed-Loop Control in Adults With Type 1 Diabetes A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management","volume":"36","author":"Luijf","year":"2013","journal-title":"Diabetes Care"},{"issue":"S1","key":"10.1016\/j.dsx.2017.07.003_bib0040","doi-asserted-by":"crossref","first-page":"S-21","DOI":"10.1089\/dia.2015.1503","article-title":"Insulin pumps","volume":"17","author":"Pickup","year":"2015","journal-title":"Diabetes Technol Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.dsx.2017.07.003_bib0045","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2337\/dc15-S005","article-title":"2: Classification and diagnosis of diabetes","volume":"38","author":"Association","year":"2015","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.dsx.2017.07.003_bib0050","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/dc14-0179","article-title":"Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study","volume":"37","author":"Duran","year":"2014","journal-title":"Diabetes Care"},{"issue":"March 2012","key":"10.1016\/j.dsx.2017.07.003_bib0055","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.003_bib0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2011","key":"10.1016\/j.dsx.2017.07.003_bib0065","first-page":"11","article-title":"Relationship of glycated albumin to blood glucose and glycated hemoglobin (HbA1C) values and to retinopathy, nephropathy and cardiovascular outcomes in the DCCT\/EDIC study","author":"Nathan","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2017.07.003_bib0070","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2337\/dc13-1929","article-title":"Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures","volume":"37","author":"Underwood","year":"2014","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.003_bib0075","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.2337\/dc13-0010","article-title":"Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes","volume":"36","author":"Sherr","year":"2013","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.003_bib0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/dom.12052","article-title":"Insulin degludec: overview of a novel ultra long-acting basal insulin","volume":"15","author":"Gough","year":"2013","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.003_bib0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.diabres.2004.02.008","article-title":"Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine","volume":"66","author":"Garg","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.003_bib0090","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/dom.12303","article-title":"Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial","volume":"16","author":"Tinahones","year":"2014","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.003_bib0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.7123\/01.EJIM.0000428094.08737.05","article-title":"HbA1c reliability in patients with diabetes on regular hemodialysis before and after erythropoietin therapy","volume":"25","author":"Abdel-Aziz","year":"2013","journal-title":"Egypt J Internal Med"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.003_bib0100","doi-asserted-by":"crossref","first-page":"e000021","DOI":"10.1136\/bmjdrc-2014-000021","article-title":"Obesity independently predicts responders to biphasic insulin 50\/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort study","volume":"2","author":"Mamza","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.003_bib0105","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2337\/diacare.28.6.1282","article-title":"Improvement of glycemic control in subjects with poorly controlled type 2 diabetes comparison of two treatment algorithms using insulin glargine","volume":"28","author":"Davies","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.003_bib0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13300-014-0068-9","article-title":"Metabolic effects of basal or premixed insulin treatment in 5077 insulin-na\u00efve type 2 diabetes patients: registry-based observational study in clinical practice","volume":"5","author":"Eliasson","year":"2014","journal-title":"Diabetes Ther"},{"issue":"4","key":"10.1016\/j.dsx.2017.07.003_bib0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00592-007-0004-9","article-title":"Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes","volume":"44","author":"Yilmaz","year":"2007","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.003_bib0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2337\/diacare.28.1.78","article-title":"The Influence of Insulin Use on Glycemic Control How well do adults follow prescriptions for insulin?","volume":"28","author":"Cramer","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2017.07.003_bib0125","doi-asserted-by":"crossref","unstructured":"Steineck I, Cederholm J, Eliasson B, Rawshani A, Olofsson K, Svensson A, et al. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study, 2015.","DOI":"10.1136\/bmj.h3234"},{"issue":"2","key":"10.1016\/j.dsx.2017.07.003_bib0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00592-013-0481-y","article-title":"A 7-year follow-up retrospective, international multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes","volume":"51","author":"Mameli","year":"2014","journal-title":"Acta Diabetol"},{"issue":"9","key":"10.1016\/j.dsx.2017.07.003_bib0135","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.metabol.2015.05.011","article-title":"Sliding-scale insulin used for blood glucose control: a meta-analysis of randomized controlled trials","volume":"64","author":"Lee","year":"2015","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.003_bib0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.dsx.2015.04.011","article-title":"Comparison of the effects of intensive insulin treatment modalities on cardiovascular biomarkers in type 1 diabetes mellitus","volume":"9","author":"Cetinkalp","year":"2015","journal-title":"Diabetes Metab Syndrome: Clin Res Rev"},{"year":"2013","series-title":"The effects of aerobic and resistance exercise on inflammatory markers and metabolic control in healthy individuals and type 1 diabetics using either insulin pump or multiple dose injection","author":"Alblihed","key":"10.1016\/j.dsx.2017.07.003_bib0145"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.003_bib0150","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/jpepsy\/jsj088","article-title":"Insulin pump therapy and health-related quality of life in children and adolescents with type 1 diabetes","volume":"31","author":"Valenzuela","year":"2006","journal-title":"J Pediatr Psychol"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.003_bib0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1399-5448.2008.00494.x","article-title":"A randomized prospective study of insulin pump vs. insulin injection therapy in very young children with type 1 diabetes: 12\u2010month glycemic, BMI, and neurocognitive outcomes","volume":"10","author":"Nabhan","year":"2009","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.003_bib0160","first-page":"375","article-title":"Hypertension management in primary care: standard care and attitude towards a disease management model","volume":"62","author":"Wassenberg","year":"2004","journal-title":"Neth J Med"},{"issue":"9982","key":"10.1016\/j.dsx.2017.07.003_bib0165","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0140-6736(15)60936-9","article-title":"Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study","volume":"385","author":"Blonde","year":"2015","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.dsx.2017.07.003_bib0170","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2337\/dc12-2508","article-title":"Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action","volume":"36","author":"Draznin","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.003_bib0175","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/dc06-1755","article-title":"Perceptions of psychosocial factors and the insulin pump","volume":"30","author":"Ritholz","year":"2007","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.dsx.2017.07.003_bib0180","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1464-5491.2010.03058.x","article-title":"Continuous subcutaneous insulin infusion in Type 1 diabetes: patient experiences of \u2018living with a machine\u2019","volume":"27","author":"Todres","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2017.07.003_bib0185","article-title":"Analysis of insulin pump settings in children and adolescents with type 1 diabetes mellitus","author":"Lau","year":"2015","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.003_bib0190","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/pedi.12263","article-title":"Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes","volume":"16","author":"Thalange","year":"2015","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.003_bib0195","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/JHQ.0000000000000004","article-title":"Improving glycemic control and insulin ordering efficiency for hospitalized patients with diabetes through carbohydrate counting","volume":"38","author":"Pearson","year":"2016","journal-title":"J Healthc Qual"},{"issue":"7","key":"10.1016\/j.dsx.2017.07.003_bib0200","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4158\/EP14153.OR","article-title":"Effectiveness of inpatient insulin order sets using human insulins in noncritically ill patients in a rural hospital","volume":"21","author":"Valgardson","year":"2015","journal-title":"Endocr Pract"},{"issue":"43","key":"10.1016\/j.dsx.2017.07.003_bib0205","first-page":"44","article-title":"Diabetes and clinical research","volume":"5","author":"Ahmad","year":"2014","journal-title":"Clin Trials (Market Available)"},{"issue":"8","key":"10.1016\/j.dsx.2017.07.003_bib0210","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.2337\/dc14-0001","article-title":"Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro","volume":"37","author":"Rosenstock","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.dsx.2017.07.003_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40200-015-0152-3","article-title":"Safety of intravenous insulin aspart compared to regular human insulin in patients undergoing ICU monitoring post cardiac surgery: an Indian experience","volume":"14","author":"Chawla","year":"2015","journal-title":"J Diabetes Metab Disord"},{"issue":"3","key":"10.1016\/j.dsx.2017.07.003_bib0220","doi-asserted-by":"crossref","first-page":"164","DOI":"10.14499\/indonesianjpharm25iss3pp164","article-title":"Substantiation on short term efficacy and safety of insulin analogues In north indian superspeciality hospital","volume":"25","author":"Koladi","year":"2014","journal-title":"Indonesian J Pharm"},{"issue":"8","key":"10.1016\/j.dsx.2017.07.003_bib0225","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4239\/wjd.v6.i8.1045","article-title":"Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitus","volume":"6","author":"Hashimoto","year":"2015","journal-title":"World J Diabetes"},{"issue":"6","key":"10.1016\/j.dsx.2017.07.003_bib0230","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jdiacomp.2013.05.007","article-title":"Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes","volume":"27","author":"Smiley","year":"2013","journal-title":"J Diabetes and its complications"},{"year":"2013","series-title":"The Washington Manual of Medical Therapeutics","author":"Godara","key":"10.1016\/j.dsx.2017.07.003_bib0235"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117301571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117301571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:07:16Z","timestamp":1761728836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402117301571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":47,"alternative-id":["S1871402117301571"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2017.07.003","relation":{},"ISSN":["1871-4021"],"issn-type":[{"type":"print","value":"1871-4021"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of current trends and recent development in insulin therapy for management of diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}